SI-BONE (NASDAQ:SIBN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.04, Yahoo Finance reports. SI-BONE had a negative return on equity of 25.14% and a negative net margin of 29.93%. The firm had revenue of $39.97 million for the quarter, compared to the consensus estimate of $38.95 million. During the same quarter last year, the business posted ($0.30) earnings per share.
SI-BONE Trading Up 0.6 %
SIBN traded up $0.09 during mid-day trading on Wednesday, hitting $14.31. 25,584 shares of the stock were exchanged, compared to its average volume of 404,265. The company has a market cap of $589.72 million, a PE ratio of -13.05 and a beta of 1.20. The company has a current ratio of 9.76, a quick ratio of 8.75 and a debt-to-equity ratio of 0.22. The firm’s fifty day moving average is $14.05 and its two-hundred day moving average is $15.92. SI-BONE has a 1-year low of $11.76 and a 1-year high of $23.81.
Insider Transactions at SI-BONE
In other news, CFO Anshul Maheshwari sold 2,441 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $15.14, for a total value of $36,956.74. Following the sale, the chief financial officer now directly owns 204,241 shares in the company, valued at $3,092,208.74. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Anshul Maheshwari sold 2,441 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $15.14, for a total value of $36,956.74. Following the sale, the chief financial officer now owns 204,241 shares of the company’s stock, valued at $3,092,208.74. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Anthony J. Recupero sold 3,309 shares of the stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $12.92, for a total transaction of $42,752.28. Following the completion of the sale, the insider now directly owns 243,629 shares in the company, valued at $3,147,686.68. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,956 shares of company stock valued at $172,480. 5.40% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Get Our Latest Research Report on SIBN
SI-BONE Company Profile
SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
Featured Articles
- Five stocks we like better than SI-BONE
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Nuclear Power Giant’s Shares Jump on Raised Full-Year Guidance
- How to Invest in Small Cap StocksĀ
- Airbnb Stock: Key Drivers Indicate Bright Future Despite Sell-Off
- 3 Fintech Stocks With Good 2021 Prospects
- Amgen’s MariTide Weight Loss Potential: Stock Outlook
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.